35-204
Estudio prospectivo de profilaxis ambulatoria con sulodexida despues de una artroplastia total de cadera o rodilla
Prospective study of ambulatory thromboprophylaxis with sulodexide after total hip or knee arthroplasty
R. RAMOS GALEA*, J. BUNCO BLANCO**, P. HERNÁNDEZ MARTÍN**, D. BORREGO RATERO**, M. GARCÍA ALONSO* *SERVICIO DE COT HOSPITAL UNIVERSITARIO DEL RÍO HORTEGA. VALLADOUD. **SERVICIO DE COT. HOSPITAL VIRGEN DE LA VEGA. SALAMANCA.
Recepción:
15/09/2008
Aceptación:
15/09/2008
Publicación:
15/09/2008
Métricas
72
Visualizaciones
Compartir
Compartir
Resumen (ES)
The discontinous thromboprophylaxis is a determinant
cause in the presence of thromboembolic complications
in the first month after hospital discharge. The difficult
administration of the low-molecular- weight heparin by the
patient and the different preoccupation for this problem
between the Primary Care and the orthopedics specialists
are the causes that incite to discontinous thromboprophylaxis.
A prospective study was made of 221 patients who
undergoing a total hip arthroplasty or a total knee arthroplasty
and the objetive was to investigate the incidence of
venous thrombosis in the patients who were treated with
oral sulodexide in the firts month after hospital discharge.
We analized the efficacy and the secondary effects of sulodexide.
There were satisfactory results in 98,8% of patients
who were treated with sulodexide (1,2% of venous complications),
and 21% of venous complications in the group of
patients who did not continue the thromboprophylactic treatment.
cause in the presence of thromboembolic complications
in the first month after hospital discharge. The difficult
administration of the low-molecular- weight heparin by the
patient and the different preoccupation for this problem
between the Primary Care and the orthopedics specialists
are the causes that incite to discontinous thromboprophylaxis.
A prospective study was made of 221 patients who
undergoing a total hip arthroplasty or a total knee arthroplasty
and the objetive was to investigate the incidence of
venous thrombosis in the patients who were treated with
oral sulodexide in the firts month after hospital discharge.
We analized the efficacy and the secondary effects of sulodexide.
There were satisfactory results in 98,8% of patients
who were treated with sulodexide (1,2% of venous complications),
and 21% of venous complications in the group of
patients who did not continue the thromboprophylactic treatment.
Palabras clave (ES):
Embolismo
Pulmonar
Sulodexia
Ambulatoria
Embolia
Tromboembolismo
Venoso
Venosa
Trombosis
Antitrombótica
Profilaxis
Resumen (EN)
The discontinous thromboprophylaxis is a determinant
cause in the presence of thromboembolic complications
in the first month after hospital discharge. The difficult
administration of the low-molecular- weight heparin by the
patient and the different preoccupation for this problem
between the Primary Care and the orthopedics specialists
are the causes that incite to discontinous thromboprophylaxis.
A prospective study was made of 221 patients who
undergoing a total hip arthroplasty or a total knee arthroplasty
and the objetive was to investigate the incidence of
venous thrombosis in the patients who were treated with
oral sulodexide in the firts month after hospital discharge.
We analized the efficacy and the secondary effects of sulodexide.
There were satisfactory results in 98,8% of patients
who were treated with sulodexide (1,2% of venous complications),
and 21% of venous complications in the group of
patients who did not continue the thromboprophylactic treatment.
cause in the presence of thromboembolic complications
in the first month after hospital discharge. The difficult
administration of the low-molecular- weight heparin by the
patient and the different preoccupation for this problem
between the Primary Care and the orthopedics specialists
are the causes that incite to discontinous thromboprophylaxis.
A prospective study was made of 221 patients who
undergoing a total hip arthroplasty or a total knee arthroplasty
and the objetive was to investigate the incidence of
venous thrombosis in the patients who were treated with
oral sulodexide in the firts month after hospital discharge.
We analized the efficacy and the secondary effects of sulodexide.
There were satisfactory results in 98,8% of patients
who were treated with sulodexide (1,2% of venous complications),
and 21% of venous complications in the group of
patients who did not continue the thromboprophylactic treatment.
Explorar
Artículos
Volúmenes
Sobre la revista